ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

PAUL GREENE D.O.

373 CECIL D QUILLEN DR SUITE 101

Duffield | Virginia | 24244

(276) 431-1638

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,781Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 1692

$737K Total Retail Price of All Prescriptions

Rank: 97 out of 1692

353 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 353 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

47% of this provider’s 353 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,358 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 882 228 S3 1 6
OMEPRAZOLE 478 306 2 5
FUROSEMIDE 390 271 3 7
LISINOPRIL 336 200 4 2
SIMVASTATIN 308 261 5 1
POTASSIUM CHLORIDE 306 186 6 20
GABAPENTIN 299 113 7 13
WARFARIN SODIUM 293 229 8 14
LEVOTHYROXINE SODIUM 288 237 9 4
DONEPEZIL HCL 257 245 10 29
METOPROLOL TARTRATE 242 196 11 10
ZOLPIDEM TARTRATE 241 72 12 23
LACTULOSE 194 164 13 104
TRAMADOL HCL 174 47 14 16
QUETIAPINE FUMARATE 167 116 15 62
MIRTAZAPINE 162 127 16 53
POLYETHYLENE GLYCOL 3350 158 126 17 64
METFORMIN HCL 153 66 18 8
NAMENDA 152 152 19 50
TRAZODONE HCL 146 71 20 33
CYMBALTA 137 72 21 51
PAROXETINE HCL 135 88 22 60
LANTUS 135 98 22 57
ISOSORBIDE MONONITRATE ER 134 116 24 55
SERTRALINE HCL 126 83 25 22
PANTOPRAZOLE SODIUM 125 82 26 39
AZITHROMYCIN 121 60 27 34
AMLODIPINE BESYLATE 118 91 28 3
TAMSULOSIN HCL 117 89 29 31
RISPERIDONE 117 74 29 77
NEXIUM 116 40 31 25
ATENOLOL 114 58 32 15
TIZANIDINE HCL 113 0 33 127
IBUPROFEN 112 22 34 78
CITALOPRAM HBR 105 62 35 21
PRAVASTATIN SODIUM 105 52 35 12
HALOPERIDOL 100 88 37 165
FAMOTIDINE 94 62 38 86
CLOPIDOGREL 93 68 39 43
CIPROFLOXACIN HCL 90 77 40 65
HYDROCHLOROTHIAZIDE 88 48 41 9
PROMETHAZINE HCL 82 31 R 42 81
CARVEDILOL 78 47 43 24
ATORVASTATIN CALCIUM 77 56 44 11
PROAIR HFA 77 25 44 40
CYCLOBENZAPRINE HCL 73 38 R 46 54
METOPROLOL SUCCINATE 73 52 46 18
PHENYTOIN 72 20 48 306
SPIRIVA 72 36 48 44
PLAVIX 70 44 50 66
FLUOXETINE HCL 70 15 50 52
DIGOXIN 69 57 52 85
GLIPIZIDE 69 65 52 47
DIVALPROEX SODIUM 67 51 54 97
MELOXICAM 66 39 55 41
ALBUTEROL SULFATE 66 65 55 115
KLOR-CON M20 66 43 55 48
NOVOLIN R 62 57 58 197
CEPHALEXIN 61 40 59 89
CLONIDINE HCL 61 35 59 46
GLIMEPIRIDE 60 44 61 32
OLANZAPINE 59 50 62 145
NOVOLOG 59 29 62 120
ZETIA 58 34 64 68
SPIRONOLACTONE 58 46 64 74
DIOVAN 56 0 66 42
NYSTATIN 54 42 67 150
CEFTRIAXONE 54 44 67 253
FINASTERIDE 53 52 69 99
MUPIROCIN 50 30 70 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.